ESMO 2019: Die wichtigsten Take-Home Messages aus Barcelona
medONLINE,
Von vielversprechend bis praxisverändernd: Das sind die Highlights unserer Interviewpartner am ESMO 2019. …
LBA30_PR Analysis of circulating tumour DNA (ctDNA) from patients enrolled in the IDEA-FRANCE phase III trial: Prognostic and predictive value for adjuvant treatment duration
Overview of attention for article published in Annals of Oncology, October 2019
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
Good Attention Score compared to outputs of the same age (79th percentile)
-
Good Attention Score compared to outputs of the same age and source (74th percentile)
Readers on
- mendeley
- 61 Mendeley